Zylet FDA Approval History
FDA Approved: Yes (First approved December 14, 2004)
Brand name: Zylet
Generic name: loteprednol and tobramycin
Dosage form: Ophthalmic Suspension
Company: Bausch & Lomb
Treatment for: Uveitis, Iritis, Conjunctivitis, Bacterial, Keratitis, Cyclitis
Zylet (loteprednol etabonate and tobramycin ophthalmic suspension) a topical anti-inflammatory corticosteroid and antibiotic combination for use in the treatment of inflammatory ocular conditions.
Development Timeline for Zylet
|Dec 14, 2004||Zylet Bausch & Lomb - Treatment for Inflammatory Ocular Conditions|
|Aug 9, 2004||FDA Issues Approvable Letter to Bausch & Lomb for Ophthalmic Anti-inflammatory/Antibiotic Combination Product|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.